These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11558458)
41. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762 [TBL] [Abstract][Full Text] [Related]
42. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. Mayer KH; Maslankowski LA; Gai F; El-Sadr WM; Justman J; Kwiecien A; Mâsse B; Eshleman SH; Hendrix C; Morrow K; Rooney JF; Soto-Torres L; AIDS; 2006 Feb; 20(4):543-51. PubMed ID: 16470118 [TBL] [Abstract][Full Text] [Related]
43. Trials begin on HIV gel for women. AIDS Read; 2007 Aug; 17(8):421-2. PubMed ID: 17722252 [No Abstract] [Full Text] [Related]
44. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. D'Cruz OJ; Waurzyniak B; Uckun FM Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159 [TBL] [Abstract][Full Text] [Related]
45. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis. Simbar M; Azarbad Z; Mojab F; Majd HA Phytomedicine; 2008 Dec; 15(12):1025-31. PubMed ID: 18824338 [TBL] [Abstract][Full Text] [Related]
46. Test of new vaginal microbicide gel show promise for women. AIDS Read; 2008 Apr; 18(4):165-6. PubMed ID: 18467997 [No Abstract] [Full Text] [Related]
47. New technologies promise safer sex for women. May M Nat Med; 2009 Sep; 15(9):979. PubMed ID: 19734859 [No Abstract] [Full Text] [Related]
48. Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study. Taulo F; Berry M; Tsui A; Makanani B; Kafulafula G; Li Q; Nkhoma C; Kumwenda JJ; Kumwenda N; Taha TE AIDS Behav; 2009 Jun; 13 Suppl 1():20-7. PubMed ID: 19308718 [TBL] [Abstract][Full Text] [Related]
49. The use of the diaphragm instead of condoms in a phase III diaphragm trial. van der Straten A; Cheng H; Moore J; Kacanek D; Blanchard K; De Bruyn G; Ramjee G; Chipato T; Montgomery ET; Padian N; AIDS Behav; 2009 Jun; 13(3):564-72. PubMed ID: 19085099 [TBL] [Abstract][Full Text] [Related]
50. [Experiment in affecting cancer biologically with an intramuscular and local administration of the seaweed, Scenedesmus obliquus]. Drnek F; Prokes B; Rydlo O Cesk Gynekol; 1981 Jul; 46(6):463-5. PubMed ID: 7261099 [No Abstract] [Full Text] [Related]
51. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? Njoroge B; Chirenje ZM; Pandey B; Mirembe F; Joshi S; Low-Beer N; Maslankowski LA J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3():S150-1. PubMed ID: 16419263 [No Abstract] [Full Text] [Related]
52. Vaginal lubricant gel as an artefact on a Pap smear. Martínez-Girón R; Martínez-Torre S; Fernández-García C Diagn Cytopathol; 2011 Jun; 39(6):431. PubMed ID: 20949453 [No Abstract] [Full Text] [Related]
53. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169 [TBL] [Abstract][Full Text] [Related]